PEACCEL mentioned as a AI start-up to watch by NVIDIA
6 April 2021
PEACCEL mentioned as a AI start-up to watch by NVIDIA.Three Trends for Healthcare AI Startups To Watch Renee Y. | 19 mars 2021
https://www.linkedin.com/pulse/three-trends-healthcare-ai-startups-watch-renee-yao
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).
6 April 2021
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).
PEACCEL awarded by Wealth & Finance
15 February 2021
PEACCEL has just received two Artificial Intelligence Awards from Wealth & Finance :
– Best Drug Development AI Partner 2020
– Most Innovative Clinical Data Science Platform : innov’SAR
PEACCEL awarded by CIO Review
25 January 2021
PEACCEL has just been nominated as most promising biotech solutions providers in Europe 2021.
Click the links below for more details:
PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany
3 February 2020
Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2020.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany
18 October 2019
Meet PEACCEL at Protein Engineering Congress EU.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.